Oragenics Declines Comment on Unusual Market Activity

by Charles Gross, Benzinga Editor
January 13, 2014 2:44 PM | 16 seconds read | Make a Comment
Loading...
Loading...
Oragenics (NYSE MKT:
OGEN
) today announced that in view of the unusual market activity in the Company's stock, the NYSE MKT has contacted the Company in accordance with its usual practice. The Company stated that its policy is not to comment on unusual market activity.
See full press release
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsGuidanceManagementIPOsGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!